Thrive Capital Management, LLC

Q2 2021 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Ashwin Budhiraja - Chief Financial Officer
Location
New York, NY
Holdings as of
30 Jun 2021
Value $
$815M
Num holdings
6
Filing time
18 Nov 2022, 16:51:10 UTC
Form type
13F-HR/A-1 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included VMEO, AFRM, HIMS, COMP, and TWLO.
Previous filing
Q1 2021 - 18 Nov 2022
Next filing
Q3 2021 - 18 Nov 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q2 - Restatement compared to 2021 Q1 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Ashwin Budhiraja Chief Financial Officer New York, New York 18 Nov 2022

This Amendment is being filed solely for the purpose of removing from the Form 13F Information Table certain shares of Class A Common Stock of Oscar Health, Inc. ("Class A Common") inadvertently included in the Form 13F filed by the Reporting Person for the quarter ended June 30, 2021. As of June 30, 2021, the Reporting Person or its affiliates exercised investment discretion over 32,859,064 shares of Class B Common Stock of Oscar Health, Inc. ("Class B Common"). While shares of Class A Common are Section 13(f) securities as defined in Rule 13f-1(c) under the Securities and Exchange Act of 1934, shares of Class B Common are not Section 13(f) securities and thus not reportable. For the avoidance of doubt, this Amendment is to correct a clerical error only, and there were no sales by the Reporting Person of shares of Class A Common or Class B Common during the quarter ended June 30, 2021.